Avidity Biosciences
RNAM
#1874
Rank
HK$88.11 B
Marketcap
HK$570.40
Share price
0.00%
Change (1 day)
143.85%
Change (1 year)

Avidity Biosciences (RNAM) Fails to deliver data

Key failure to deliver metrics for Avidity Biosciences:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Avidity Biosciences (RNAM) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Avidity Biosciences (RNAM) - since 2020

Volume in USD (price x number of shares), data since 2020

Avidity Biosciences (RNAM) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026HK$0.92 M-98.13%
2025HK$49.36 M206.29%
2024HK$16.11 M267.16%
2023HK$4.38 M-91.34%
2022HK$50.7 M162.44%
2021HK$19.31 M-77.68%
2020HK$86.53 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
HK$63.7 MHK$0.15 B๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$54.36 MHK$0.23 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
HK$11.5 MHK$25.12 M๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
HK$4.91 MHK$22.44 M๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$0.34 MHK$1.03 M๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
N/AHK$0.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
HK$16.85 MHK$17.59 M๐Ÿ‡บ๐Ÿ‡ธ USA